Brain Res Bull. 2025 Dec 30. pii: S0361-9230(25)00522-2. [Epub ahead of print]
111710
Fragile X syndrome (FXS) stands as the predominant single gene mutation pathogenic factor linked to autism spectrum disorder (ASD), and it constitutes an inherited intellectual disability rooted in the disruption of fragile X messenger ribonucleoprotein 1 gene (FMR1). The neurodevelopmental disorder is characterized by synaptic dysfunction manifesting as the impairment of cognitive function and social communication. Wnt/β-catenin pathway plays a pivotal role in regulating synaptic structural remodeling and functional homeostasis, critically contributing to higher-order neural processes such as learning and memory. Studies have identified glycogen synthase kinase 3 beta (GSK3β), a key negative regulator of Wnt signal transduction, is abnormally activated in the pathophysiology of FXS, and demonstrated that GSK3β inhibition partially rescues cognitive and behavioral deficiencies in FXS mice. However, the spatiotemporal dysregulation of β-catenin dynamics and its synaptic consequences remain poorly understood. In this study, we aim to investigate the role and molecular mechanism of Wnt/β-catenin pathway during the developmental stages of FXS. Fmr1 gene knockout (Fmr1 KO) mice were utilized as a model for FXS. We systematically explored β-catenin homeostasis across subcellular compartments. Our results showed that there was an increased phosphorylation of β-catenin at Ser33,37, Thr41 and Ser552 residues, which foster its degradation. This was accompanied by reduced levels of active β-catenin in the membrane, cytoplasm and nucleus within the hippocampus (Hipp) and prefrontal cortex (PFC) of Fmr1 KO mice. Confocal microscopy further demonstrated diminished co-localization of β-catenin with N-cadherin, leading to compromised intercellular adhesion in both Fmr1 KO neurons. Moreover, FXS mice showed impaired neuronal morphology and deficiencies in social and cognitive functions, which are associated with the downregulation of pre- and postsynaptic proteins targeted by Wnt pathway. Strikingly, pharmacological activation of Wnt signal transduction restored β-catenin nuclear translocation and synaptic protein expression, rescuing neuronal ultrastructural abnormalities and improving cognitive and social behaviors. Our findings establish hypoactivity of canonical Wnt signaling as a central mechanism underlying synaptic pathology in FXS, linking β-catenin destabilization to altered neuronal morphology, aberrant synaptic protein networks, and behavioral phenotypes. Consequently, bolstering Wnt pathway may represent a promising neuroprotective strategy for precision intervention in FXS.
Keywords: Fmr1; Fragile X syndrome; Wnt/β-catenin pathway; neuronal morphology; presynaptic and postsynaptic protein